Trials / Sponsors / dr. Tom van der Hulle
dr. Tom van der Hulle
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Cabozantinib Dose Skipping as an Alternative to Dose Reductions Renal Cell Carcinoma (RCC) | Phase 2 | 2026-01-01 |
| Completed | The Pharmacological Effects of Using Cabozantinib With a Light Breakfast Renal Cell Carcinoma | Phase 2 | 2023-05-25 |